Adare Pharmaceutical Technologies (PT) is the specialty CDMO business unit of Adare, a global specialty pharmaceutical company. A science-driven provider of dosage form solutions for the healthcare industry – with expertise in taste masking and customized drug release – Adare PT is a leading partner to pharmaceutical companies across branded, specialty, 505b2, generic and OTC segments. With over 30 years of proven legacy, Adare PT focuses on oral dosage forms for small molecules across all therapeutic areas. To learn more, email us at BusDev@adarepharma.com.
ADM-SIO is a global leading manufacturer of pharmaceutical grade oils (soybean, olive, sesame) used as API’s or excipients for oil-soluble drugs. As a subsidiary of Archer Daniels Midland Company (ADM) –– ADM-SIO offers an extensive range of highly purified oils, derived from vegetable origins that meet all relevant pharmaceutical regulations and manufactured according to cGMP standards. Our highly purified pharmaceutical oils are used as API’s (CEP for soybean and olive oils) in large volume emulsions for parenteral nutrition and as excipients (US DMF type IV for soybean, olive and sesame oils) in injectable, oral or topical formulations.
Ajinomoto Co., Inc. is a global technology oriented company in the field of Foods, Nutrition, Fine Chemicals and Bio Pharmaceuticals, and also one of the largest amino acid manufacturer in the world. Ajinomoto Co., Inc. provide Pharmaceutical and Bio Tech Companies with unique and wide range of platform technologies which can add value onto the drug candidates. For examples, we have drug delivery technologies such as bio based nano particle for anticancer small molecules and Nucleotides, and prodrug technology applicable for both small molecules and large molecules to extend half-life etc.
Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with more than 80 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.
Aquaporin A/S has focused on developing technologies for polymersome-based stabilization of membrane proteins, the class of proteins that counts for more than 50% of all drugs on the market. The success of this development was key to functionally incorporating Nature’s highly selective water-transportation protein, known as an “aquaporin”, into flat sheet membranes. Since then, Aquaporin has initiated commercial production of millions of square meters of the most innovative water filtration membrane in the world.
Aquaporin’s polymersome technology yields several obvious advantages over other methods for membrane protein stabilization commonly used in the field: the capability for bulk production of stabilized membrane proteins enables their use in new industrial applications currently challenged by complex surface-chemistry and unspecific separations; the polymers used to generate polymersomes can be rationally altered to optimize stabilization of new membrane proteins; protein stability is often increased when reconstituted in polymersomes.
Aquaporin A/S is looking for collaboration partners that wish to actively engage in co-development of new membrane-protein applications using our polymersome technology. We have experienced all development phases: from protein expression, to detergent screening, to functional reconstitution by improving the polymersome technology. This enabled our large-scale production of Aquaporin Inside® membranes. We believe we can do the same with you and together gain new insights into your membrane protein application.
Arcinova is a UK-based Custom Research and Development Organisation (CRDO) serving the global pharmaceutical and biotechnology communities.
From our single 15,000m2 facility, which has benefited from more than 36 years of investment as a key R&D centre for Sanofi and Covance, we can support our clients’ needs with a wide range of services such as: drug substance development and manufacturing (including GMP, [14C]-labelled products and high potents), material sciences, formulation and drug product manufacturing.
We can manufacture both drug substance and drug products from grams to multi-kilo scale.
We also offer supporting analytical services including, investigations and development of QC specifications, microbiological and stability testing as well as a regulatory CMC dossier writing service.
Finally, our experienced bioanalytical team can develop, validate and implement bioanalytical assays for small and large molecule drugs, generics and biomarkers to support both clinical and non-clinical studies.
ARMOR PHARMA manufactures and markets 3 ranges of pharmaceutical grade lactose for all your applications:
A division of Avivia BV – Experts in excipient characterization
Excipia is a knowledge platform commenced after experiencing the consequences of reactivity and batch-to-batch variability of excipients, in combination with inadequate information on the Certificate of Analysis of these excipients.
Within Excipia we have setup numerous analytical procedures to reveal and compare the ‘hidden features’ of all kind of excipients. With the Excipa platform we can help examine batch-to-batch product performance variations, implement excipient related Quality by Design (QbD) approaches, perform quantitative deformulation and competitor research and analysis, monitor site changes or manufacturing process optimization, and select excipient batches to improve drug product performance without the necessity to change a registered drug product formulation.
Excipia offers hands-on troubleshooting services and solutions to pharmaceutical, generics, drug development and food companies that are encountering problems with stability, dissolution profiles, reproducibility, batch variations, etc.
Bachem provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. The group has a global reach with more experience and know-how than any other company in the industry. Bachem shows total commitment to quality, innovation and partnership.
Bachem. Pioneering Partner for Peptides
BDD is a specialist pharmaceutical development company providing expertise across all areas of drug delivery. Our service, customised to our clients individual needs, is inclusive of project design, optimal formulation development and lean clinical evaluation.
Our patented, time release technology - OralogiK™ provides unrivalled control of drug release in vivo – delivery at the right place, at the right time.
OralogiK™ enables the delivery of single, multi-dose or drug combinations at pre-determined times post dose. Benefits include:
Biopharma Group is a leading supplier of equipment and analytical services to the pharmaceutical, biotech and process industries for those using freeze drying technology, solvent removal/evaporation, high pressure homogenisation and industry related equipment. Our group compromises of dedicated divisions for:
Bosch Packaging Technology – product division Pharma is one of the leading providers of process technology and packaging solutions for the pharmaceutical industry. The portfolio includes single units, complete lines and integrated systems for the manufacturing and processing of liquid and solid pharmaceuticals. It also includes process technology, primary packaging, inspection technology for different application fields and packaging types. Secondary packaging with qualification and validation, software solutions for track and trace and technical customer service are also available.
The following product brands are part of the Bosch portfolio for the pharmaceutical industry: Hüttlin, Klenzaids, Moeller&Devicon, Pharmatec, SBM Schoeller-Bleckmann Medizintechnik, Sigpack and Valicare.
Cambridge Design Partnership is a leading product and technology innovation partner with offices in Cambridge, UK and Palo Alto, USA. We are experienced in drug delivery device design, development, prototype and short-run manufacturing for some of the world’s largest companies. Our experts in engineering, human factors and industrial design are able to take combination products through a full design cycle and submission, to enable you to launch a product that is customer focused and commercially effective. Certified to ISO 13485/9001.
Captisol is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Captisol was invented and initially developed by scientists in the laboratories of Dr. Valentino Stella, University Distinguished Professor at the University of Kansas’ Higuchi Biosciences Center for specific use in drug development and formulation. This unique technology has enabled several FDA-approved products, including Amgen’s Kyprolis®, Baxter International’s Nexterone®, Spectrum’s EVOMELA® and Melinta Therapeutics’ Baxdela™. There are many Captisol-enabled products currently in various stages of development.
confinis is a global consulting firm specializing in combination products. We are based in Switzerland and the USA. Our range of services includes:
Crux is a product development consultancy serving the pharmaceutical industry with a fully integrated service wrapped around solid technical knowledge. Our highly experienced technical team consists of designers, engineers, human-factors experts, electronics and software specialists who champion evidence-based problem-solving. We couple this scientific approach with world-class facilities & equipment to develop device solutions that perform in the real world.
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global health care world. Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our health care offering and its three pillars Bio Care, Pharma Care and Med Care, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Partnering up with the world’s top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure all patient’s safety and improve patients’ lives.
DFE Pharma is the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder formulations with a heritage in lactose, starch and superdisintegrants. With the addition of MCC to our portfolio DFE Pharma uniquely offers world's main excipient categories, unlocking potential synergies for you to increase your efficiency. Contact us on www.dfepharma.com
With combined decades of technical and industry expertise, DuPont, Dow, and FMC are unifying their product offerings, which service the food, pharmaceutical, and nutraceutical markets under the name DuPont Nutrition & Health. This newly combined portfolio addresses the toughest challenges its customers face in pharmaceutical applications, drug delivery systems, and productivity enhancement.
The enFuse, developed and manufactured by Enable Injections, is designed to enable user-administered subcutaneous delivery of high-volume therapeutics outside of a healthcare facility.
Bio-pharma companies collaboratively partner with Enable Injections to differentiate their portfolios with an ultimate development goal of empowering patients to achieve improved outcomes.
Enable employees are technology experts focused on an exceptional patient experience in collaboration with our bio-pharma partners.
Flexichem AB is the owner and sole manufacturer of a pharmaceutical grade chitosan, ViscosanTM. ViscosanTM is a game changer and its uniqueness open for new IP and new medical products with superior performance.
ViscosanTM has the same properties as other chitosans, such as its biodegradable, non-toxic and possess anti-microbial properties. In addition, ViscosanTM is soluble at physiological pH and does not promote inflammatory reactions. The process for its manufacturing is GMP-compliant, a Quality data File is in place and ViscosanTM has been evaluated in man with a good safety profile. Let´s discuss your company’s needs and see how ViscosanTM can help your business excel!
Foster Delivery Science focuses solely on Hot Melt Extrusion and extrusion processes to blend client API’s with polymers for several possible purposes: Solubility and bioavailability enhancement; create local delivery solutions such as drug loaded films, implants and fibers; create delivery or release profiles; and capture the powerful mixing capabilities of twin screw extruders. Operating from our new GMP facility 75 minutes from Boston in CT, we provide formulation development services, scale up, clinical trial material and ready for GMP manufacturing.
FREWITT – “WE CARE ABOUT MILLING”
At your service — through thick and thin, from coarse to fine.
Since 1946, Frewitt provides Swiss made innovative, reliable and cost effective particle size reduction processes to the pharmaceutical industry. We have the most comprehensive range of milling solutions on the market and can select the optimized product for your specific particle needs “from centimeters to nanometers”. For early stage drug development and formulation, our FreDrive-Lab platform offers total flexibility with 6 different milling technologies for processing only grams of product up to several kg per hour, this with seamless scalability to our family of large scale manufacturing equipment. Latest additions to our FreDrive-Lab, the NanoWitt high performance bead mill brings another dimension to particle size reduction by wet nano milling down to 50 nanometers.
Profile coming soon.
Grace, built on talent, technology and trust, is a premier specialty chemicals company that provides innovative products, technologies and services that support pharmaceutical development and manufacturing. As a worldwide leader in specialty silica gel manufacturing, Grace’s portfolio of solutions for the pharmaceutical industry include SYLOID® formulation excipients, SILSOL® silica-based drug delivery technologies, custom intermediates and regulatory starting materials, and VYDAC® and DAVISIL® bulk chromatographic resins.
Halo Labs is all about particle analysis. We live to find particles, analyze them, count them, and help our customers characterize them to better their biopharmaceutical products. Using the latest optics and innovative algorithms, Horizon, our flagship product, can analyze sub visible and visible particles, including protein aggregates. It utilizes a plate-based approach that enables high-throughput (up to 96 samples/run), low-volume (as little as 30 µL) particle analysis in a wide-range of samples from pre-formulation through quality control. Come by our booth to learn more or visit us anytime at halolabs.com.
Honeywell is a leading technology supplier to industrial end markets. We develop advanced materials, process technologies, automation solutions, and industrial software that are revolutionizing industries around the world. Honeywell is a leading supplier for pharmaceutical high barrier films called Aclar® and Aclar Accel.
Hovione offers customized services and innovative solutions from drug substance to drug product, with all activities performed at the same site, providing a fully integrated service for clinical and small commercial scale complex drug product development and manufacturing. As the Leader in Commercial Spray Drying, Hovione can handle projects from development to market. Our particle engineering technologies can address challenges in solubility enhancement, lung delivery, modified release and taste-masking applications and can handle highly potent compounds. Hovione also offers integrated inhalation development services. We do well what is difficult, to give our customers what they cannot find elsewhere.
Intract Pharma Ltd specialises in creating oral therapeutics with optimised clinical efficacy. Intract's oral formulation technologies are incorporated into several clinical stage products, one of which has passed a phase III trials and will be marketed in 2019.
Intract utilises its specialist GI models to predict drug behaviour following oral dosing, and to ensure appropriate formulation dissolution characteristics in advance of preclinical and clinical analysis.
In 2017 Intract launched Soteria, an oral biologics delivery platform which protects biologic drugs and enhances permeation into GI tissue. Soteria offers the potential to revolutionise the way in which biologics are administered for a multitude of diseases, in a number of commercially attractive markets.
Leon-nanodrugs GmbH (Munich) is a nanotechnology-based drug development company focused on development of novel oral and parenteral formulations and innovative drug combinations.
The proprietary and patent-protected MicroJetReactor Technology by leon-nanodrugs is a bottom-up approach for nano- and microparticle synthesis. Basis of the process is a continuous solvent / non-solvent precipitation that is performed under precisely controlled process conditions.
Build on its “network of expertise”, leon-nanodrugs can provide a 360 degree competence range – from concept to product approval.
Leon-nanodrugs proprietary MJR® Technology offers access to the next generation nano formulated drugs with added patient benefits and economical values for its partners and shareholders.
Lonza Pharma & Biotech provides global contract development and manufacturing services that enable pharma and biotech companies to bring medical innovations to patients in need. We are recognized for our reliability and high-quality, our global capacity, our innovative technology platforms, and our extensive experience. We have helped to commercialize pioneering therapies and we continuously invest and innovate to meet your expectations also for future medicines. Our belief is that the best outcome –for you and for your patients –comes as a result of a successful collaboration. Together, we can solve the next challenge and bring your next medicine to life.
WE MAKE APIs PERFORM
Losan is a pharma-technology company specialised in the development and manufacture of value-added drugs. Since 1992, we have manufactured products for clients in more than 70 countries worldwide and have successfully passed inspections by the US-FDA, ANVISA, and the Russian Authority. Our team of experts has successfully finalized numerous projects from design to commercial manufacturing that meet specific release profiles, optimised bioavailability, improvement of solubility, active stabilisation, taste-masking and improved administration. Our core competencies are in: HME and nano formulations, silica amourph embedding, pellet coating, granules, effervescent and orodispersible formulations, retard formulations and stick packs.
LTS is the global leader in the development and manufacture of transdermal systems and oral thin films with additional innovative technologies in development. The products developed by LTS comprise a multitude of innovations, such as first and only patch for treatment of Alzheimer and the only patch against Parkinson’s and Restless-Legs-Syndrome, which is the first medication in the world available only as a patch. The innovation capability of LTS led the way for oral thin film products on the market with the introduction of Listerine® Pocketpaks®, which dominate the North American market. LTS supports its cooperation partners from product inception through commercialization in our FDA approved facilities in Germany and USA. More than 3,000 patents reinforce the top position of LTS group in development of its technologies. LTS Lohmann services include: Feasibility studies Full product development Clinical studies phase I-IV Scale-up and process development Commercial manufacturing For transdermal therapeutic systems, topical patches and oral thin films (OTF)
Lubrizol Life Science is your trusted development partner, specializing in helping customers from idea to execution by designing and producing effective drug delivery products. We are your preferred Contract Development and Manufacturing Organization (CDMO) for complex pharmaceuticals, providing differentiated polymers and excipients, state-of-the-art design, development and manufacturing services. Staffed by industry experts, Lubrizol Life Science offers drug product formulation and a comprehensive suite of supporting services. Lubrizol Life Science: Driven by innovation, powered by partnership.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm are experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established R&D centres in the USA and UK and has its global HQ in Guildford, UK.
Merck KGaA, Darmstadt, Germany is a leading science and technology company in healthcare, life science and performance materials. We offer more than 400 pharmaceutical formulation raw materials for solid, liquid and semi-solid dosage forms, a wide range of active pharmaceutical ingredients and drug delivery compounds which include activated PEGs, lipids, PEG lipids for bioavailability enhancement. In addition, our Emprove® Program provides extensive regulatory documentation to facilitate risk assessment and qualification processes. Through dedicated collaboration on new scientific and engineering insights, we serve as a strategic partner to help advance the promise of life saving therapies. For more information on the company's portfolio, please click here.
MUNIT is a consultancy company, operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics.
In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy) making the best out of 40 years of leadership in the micronization sector.
MUNIT is your access point to JETPHARMAs and MICROCHEMs services:
Oakwood Labs specializes in the development and aseptic manufacturing of sustained-release injectable microsphere products, ranging in duration from weeks to one year, through the use of our patented Chroniject™ technology. Oakwood’s FDA approved cGMP aseptic manufacturing facility enables partners the ability to bring products from feasibility concepts, through clinical trials, to successful approval and commercialization.
Pensatech Pharma GmbH is an innovative contract drug research and development company with a comprehensive suite of classical and innovative dosage form technologies. Our experience and solid understanding in product and process development helps our customers to overcome their drug delivery challenges in an efficient manner and turn ideas into robust innovative products. The focus of Pensatech Pharma’s services is the solution-oriented design and development of dosage forms for existing and new chemical entities as well as life-cycle management. Pensatech Pharma offers a wide range of drug delivery technologies especially with difficult-to-formulate drug molecules. We provide our customers various services that support the different product development' steps, including pre-formulation, formulation and process development activities, analytical method development and stability testing. Contact us (firstname.lastname@example.org) to discuss how our different services and experience could help you during the development of your product.
Pfanstiehl Inc. is a cGMP Manufacturer of High Purity Low Endotoxin components such as Trehalose, Sucrose, Mannitol, Maltose, Galactose (non-animal), Mannose and Ribose for Biologics, Biosimilars, Vaccines, Cell Culture Media and Injectables (liquid & lyo) located in Waukegan Illinois USA. Pfanstiehl has been in operation since 1919, focusing on both Biopharmaceutical excipients / critical components & Pharmaceutical HPAPIs / APIs (generic and on contract manufacturing base). Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities.
PMC Isochem offers contract research, custom manufacturing, catalogue products and innovative solutions for Pharmaceutical companies worldwide. Our offer addresses three major areas:
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Roquette is a global leader in plant-based ingredients and a pioneer of new vegetal proteins.
Making life better!
The safety of your patients is your first objective. That's why the quality and stability of your formulations are your ultimate challenge, and ours too.
As a long-established global provider of plant-based excipients and life-saving active ingredients for the pharmaceutical and biopharmaceutical industries, Roquette offers a competitive broad-range of customer-focused solutions.
Roquette currently operates in over 100 countries, has a turnover of around 3.3 billion euros and employs 8,400 people worldwide.
Shin-Etsu PFMD is the distribution organization of Shin-Etsu Chemical Co., Ltd. Japan and SE Tylose, Wiesbaden Germany and is registered in Wiesbaden. It is located at the Industrial Park Kalle-Albert in Wiesbaden. Together with our distributors, we are the exclusive business partners for our customers and multi national key accounts in the pharmaceutical- and the food industry. SE PFMD manages a regional, centralized warehouse for all products to be able to supply the customers in Europe on short-term base whenever necessary. SE PFMD will manage logistic for customers in other regions independent from Shin-Etsu´s production sites. For our pharma customers we offer with our technical application lab the possibility to optimize their processes if required. Our products are covering a very wide range of applications and they fully comply with FDA, USP/NF, JP and EP requirements. Pharmaceutical Excipients: Cellulose ether excipient is a pharmacologically inactive substance used as a carrier for the active ingredients in medication. PHARMACOAT® – Water-Soluble Film Coating Agent METOLOSE® – Binder and Thickening Agent METOLOSE® SR – Sustained release agent for hydrophilic matrix system L-HPC – Disintegrant with Binding Properties, Multifunctional Excipient HPMCP – Enteric Coating Agent Shin-Etsu AQOAT® – Enteric Coating Agent, Solid Dispersion Polymer Tylopur® – Low- and high viscosity Hypromellose
Stéarinerie Dubois is a French family-owned company established in 1820 and specializing in the production of GMP excipients for pharmaceutical, veterinary and life sciences markets.
Our lipid-based GMP excipients are used for oral, topical, rectal, vaginal and parenteral administration routes.
They are well known for their quality and their functionality: lubricants, taste-masking agents, bioavailability enhancers, sustained release vehicles, emulsifiers, solubilizers, thickeners and spreading agents.
Quality standards: IPEC-GMP, ISO 9001, ISO 14001, FSSC 22000, RSPO, GMP, Kosher.
Surface Measurement Systems develop and engineer gravimetric sorption analyzers and inverse gas chromatography instruments for physico-chemical characterization of solid state materials. Our instruments can be used for studying sorption and desorption isotherms, vapor and gas diffusion kinetics, hysteresis effects, stability studies, water activity, phase transformations, amorphous content, permeability, surface energy heterogeneity, dispersive and acid-base surface energy, solubility parameters, heats of adsorption and works of adhesion and cohesion.
BY YOUR SIDE - FROM IDEA TO MARKET
We are your full service CDMO for transdermal patches and oral films.
As our customer, you may expect premium quality and full regulatory compliance. We allow you to reduce the number of contractors you currently work with and handle all steps of drug development and manufacturing. Our products are made in Germany, safeguarded by our quality systems under full cGMP in high quality. Considering the many changes affecting our industry, we fully comprehend your need for end-to-end services and are available as your reliable partner.
Here’s the deal. We’re all about helping biologics researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it. Key Products: Lunatic – the concentration liberator, Uncle – The first all-in-one biologics stability platform. Hunk – The total solution for quantifying stability. Grunt – The first automated buffer prep and exchange system. Freeslate – The most configurable end-to-end automated workflow solution. Junior – The most configurable benchtop workflow solution.
Upperton Pharma Solutions is an independent CDMO providing specialist Spray Drying and formulation services to the Pharmaceutical and Biotechnology industries. The company is a world-leader in Spray Drying technology, and offers a complete development package, from early stage feasibility studies and formulation development, to process optimisation, scale up and clinical trial (IMP) manufacturing, supporting a range of dosage forms. Comprehensive product testing and ICH stability studies are available through an extensive range of analytical capabilities.
Based in Nottingham, UK, and founded in 1999, our primary focus has always been on the versatile technology of Spray Drying and we have built up the expertise to support even the most challenging of molecules. The company has an extensive, multinational client-base, ranging from small start-ups to top pharma companies and we pride ourselves on our client-focused, flexible approach and scientific excellence.
VELOX, an IMCD company, is a leading pan European supplier of raw material specialties. We offer a complementary range of rigid and elastomeric polymers as well as customized compounds for the following segments: implantable and non-implantable medical devices, dental, orthopedics, drug delivery, medical and pharmaceutical packaging, diagnostics and surgical equipment.
We offer technical expertise at the design stage of new projects and have a very wide selection of sample parts and polymers which we can provide quickly from our European stock.
Design for Healthcare
Since 1976, Worrell has served medical device and pharmaceutical companies with expertise in ethnographic research, human factors and design and development programs. Working on the front lines with patients and healthcare professionals, Worrell uncovers unmet needs to bring new drug delivery, medical device and digital health solutions to market.
W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Founded in 1958, Gore has built a reputation for solving complex technical challenges in the most demanding environments — from revolutionizing the outerwear industry with GORE-TEX® fabric to creating medical devices that improve and save lives to enabling new levels of performance in the aerospace, pharmaceutical and mobile electronics markets, among other industries. As a business initiative within the Enterprise, Gore PharmBIO Products develops high-performance, technology-driven products to better serve the global pharmaceutical, bioprocessing and medical device markets. All products in the Gore PharmBIO Products portfolio are tested and manufactured under stringent quality systems. These high-performance products provide creative solutions to our customers’ design, manufacturing, and performance-in-use needs.